CardioRisk Calculator vs CPS by CPhA

CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application. CardioRisk Calculator™ provides: -quick calculations on % LDL-C reductions -concise drug dosage information -clear snapshot of a patient's CV risk -options to bring lipid levels to target -easy identification of familial hypercholesterolemia This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia. Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order): - Amgen Canada - Bayer Inc - Boehringer Ingelheim (Canada) Ltd - FH Canada - HLS Therapeutics - Janssen Inc - Novo Nordisk Canada - Sanofi Canada

CPS (formerly RxTx) has a new appearance. CPS is still the reliable, evidence-based drug resource it has always been and provides essential drug information at the point-of-care for health care practitioners. Now offering two subscription options – CPS Drug Information or CPS Full Access. CPS Drug Information is the Canadian standard for drug monographs, containing thousands of products including monographs for drugs, vaccines, natural health products and medical devices, approved by Health Canada. CPS Full Access includes all content from CPS Drug Information and the most current, evidence-based therapeutic information and non-prescription therapy for most common conditions, with cross-referenced drug tables and algorithms and DC condition-based drug tables. Both subscriptions types provide critical updates such as warnings and advisories; and useful tools such as medical calculators.